Medical Condition

anemia

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 1, Phase 4, Phase 3

ClinicalMetric tracks all active clinical trials for anemia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — anemia Clinical Trials

How many clinical trials are currently recruiting for anemia?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for anemia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for anemia?

anemia research spans Phase 1 (1 trial), Phase 2 (1 trial), Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a anemia clinical trial?

Eligibility criteria for anemia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 2

Phase 3

Phase 4

Top Sponsors

Columbia University 1 trial

Centre Hospitalier Universitaire, Amiens 1 trial

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1 trial

Pharmanutra S.p.a. 1 trial

Siriraj Hospital 1 trial

Recruiting Clinical Trials

NCT06042699

Recruiting

Kids With Iron Deficiency and Scoliosis

Genomic of CONgenital Sideroblastic Anemias

Centre Hospitalier Universitai...

View Trial →

NCT06245746 Phase 1

Recruiting

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Union Hospital, Tongji Medical...

View Trial →

NCT07308769 Phase 4

Recruiting

Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women

Guideline Adherence for Preoperative Anemia Management in a PAC

Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition (Full Scale Trial)

University of California, San ...

View Trial →

NCT07623161 Phase 3

Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Enrollment

324 pts

Location

United States, Argen...

Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)

AHS Cancer Control Alberta

View Trial →

NCT06234332

Recruiting

Peking University Birth Cohort in Weifang (PKUBC-WF)

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Swiss Tropical & Public Health...

View Trial →

NCT07055243 Phase 2

Recruiting

To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII.

University Health Network, Tor...

View Trial →

NCT06060639

Recruiting

Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients

Centre Hospitalier Universitai...

View Trial →

Related Conditions

infections (2) obesity (2) adolescent idiopathic scoliosis (1) neuromuscular scoliosis (1) perioperative postoperative complications (1) iron deficiencies (1) spinal fusion (1) postoperative cognitive dysfunction (1) genetics (1) erythropoiesis (1) acute myeloid leukemia (1) neutropenia (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology